ramp221 Feb 2019 10:13
The Company trading update of 7 January 2019 noted that Cellulac (9.35% owned by Integumen) had developed a low-cost hemp-derived CBD oil extraction process and was collaborating with Labskin to provide a formulation for the STOER For Men range of cosmetics.
Explosive growth in the hemp-derived CBD category that has grown from a market category that did not exist five years ago to $190 Million in sales in 2017, poised to have reached $1.0 Billion in 2018, is led by hemp-derived CBD, food, personal care and industrial products. Hemp Business Journal estimates the U.S. hemp industry will grow to a $1.9B market by 2022.
good pick at such low market cap, going by the sector its in, can see this easily going over 15mil